Interleukin-2 self-sufficient enhanced-Tregs for improved cell immunotherapies – Nitro
Project coordination
Michelle Rosenzwajg (DMU Medecine interne Inflammation Immunité 3 ID)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
University of Barcelona (UB)
Fundació Clínic per a la Recerca Biomèdica (FCRB)
3ID DMU Medecine interne Inflammation Immunité 3 ID
ILTOO Pharma
Centre Hospitalier Universitaire de Rouen (CHR)
Sheba Medical Centre (SMC)
Help of the ANR 16,950 euros
Beginning and duration of the scientific project:
- 12 Months
